Monday, March 30, 2015 8:47:42 PM
Therein lies the truth about this whole scenario occurring with the FDA and this "new category" creation for this NEW science of pain treatment. No acceptance of products utilizing this technology was going to be accepted by the FDA until it was understood exactly how the process of PEMF works. Educating those in power about the science was the first order of business before any acceptance was granted. By CREATING this new category we can now assume that has occurred. Understanding this science was the first order of business by the FDA. Now that it is obvious that they do believe in this science and understand the cellular healing mechanism as a credible treatment for swelling and related pain, they (the FDA) can turn their attention toward the individual products of petitioning companies for verifiable FDA approval. It's been a LONG journey but the pieces of the puzzle are finally coming together to a most sought after conclusion.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM